Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap: |
Title | Isarna Therapeutics – Leading Expertise in TGF-ß Biology and |
Description | Profound knowledge in antisense oligonucleotide Skip to the content Home The Company Pipeline News & Events Contact Us Home The Company Pipeline News & Events Contact Us Home The Company Pipeline News & |
Keywords | N/A |
WebSite | isarna-therapeutics.com |
Host IP | 109.235.61.203 |
Location | Germany |
Site | Rank |
US$896,135
Last updated: 2023-05-07 06:48:15
isarna-therapeutics.com has Semrush global rank of 11,811,062. isarna-therapeutics.com has an estimated worth of US$ 896,135, based on its estimated Ads revenue. isarna-therapeutics.com receives approximately 103,401 unique visitors each day. Its web server is located in Germany, with IP address 109.235.61.203. According to SiteAdvisor, isarna-therapeutics.com is safe to visit. |
Purchase/Sale Value | US$896,135 |
Daily Ads Revenue | US$828 |
Monthly Ads Revenue | US$24,817 |
Yearly Ads Revenue | US$297,793 |
Daily Unique Visitors | 6,894 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
isarna-therapeutics.com. 7198 | A | isarna-therapeutics.com. 7198 | IP: 109.235.61.203 |
isarna-therapeutics.com. 86400 | NS | isarna-therapeutics.com. 86400 | NS Record: ns2.werkstatt5.com. |
isarna-therapeutics.com. 86400 | NS | isarna-therapeutics.com. 86400 | NS Record: ns1.werkstatt5.com. |
isarna-therapeutics.com. 86400 | MX | isarna-therapeutics.com. 86400 | MX Record: 10 mail.d-itaas.com. |
isarna-therapeutics.com. 86400 | MX | isarna-therapeutics.com. 86400 | MX Record: 20 mail2.d-itaas.com. |
isarna-therapeutics.com. 86400 | TXT | isarna-therapeutics.com. 86400 | TXT Record: v=spf1 a mx ~all |
Skip to the content Home The Company Pipeline News & Events Contact Us Home The Company Pipeline News & Events Contact Us Home The Company Pipeline News & Events Contact Us Unravelling TGF-β for a New Class of Therapeutics isarna therapeutics READ MORE Built on deep knowlwdge in Antisense Oligonucleotide Design isarna therapeutics READ MORE Leading Expertise in TGF-ß Biology and Ophthalmology isarna therapeutics READ MORE Who We Are Profound knowledge in antisense oligonucleotide design Isarna Therapeutics was built on profound knowledge in antisense oligonucleotide design and therapeutic development of this innovative compound class. Today, Isarna is developing a portfolio of antisense therapies targeting an emerging therapeutic field in human biology - TGF-β signaling. Precise modulation of TGF-β pathways using antisense therapy may result in safer and more effective treatment options for a broad range of indications. Our lead compound, ISTH0036, is in Phase 2a clinical development |
HTTP/1.1 301 Moved Permanently Date: Wed, 27 Oct 2021 13:08:17 GMT Server: Apache Location: http://www.isarna-therapeutics.com/ Vary: Accept-Encoding Content-Type: text/html; charset=iso-8859-1 HTTP/1.1 200 OK Date: Wed, 27 Oct 2021 13:08:17 GMT Server: Apache Content-Length: 6174 X-Powered-By: PleskLin Vary: Accept-Encoding Content-Type: text/html; charset=utf-8 |
Domain Name: ISARNA-THERAPEUTICS.COM Registry Domain ID: 1825525919_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.antagus.de Registrar URL: http://www.vautron.de Updated Date: 2021-09-05T07:14:39Z Creation Date: 2013-09-04T12:57:40Z Registry Expiry Date: 2022-09-04T12:57:40Z Registrar: Vautron Rechenzentrum AG Registrar IANA ID: 1443 Domain Status: ok https://icann.org/epp#ok Name Server: NS1.WERKSTATT5.COM Name Server: NS2.WERKSTATT5.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-15T10:09:10Z <<< |